Risk of Cardiac Lesion with Chronic and Acute Use of Loperamide-An Integrative Review.

Autor: Lammoglia BC; School of Medicine, Universidade Santo Amaro (UNISA), São Paulo 04829-300, SP, Brazil., Hasselmann G; School of Medicine, Universidade Santo Amaro (UNISA), São Paulo 04829-300, SP, Brazil., Pires-Oliveira M; School of Medicine, União Metropolitana de Educação e Cultura, Lauro de Freitas 42700-000, BA, Brazil., Duarte Nicolau LA; Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (LAFIDG), Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba 64202-020, PI, Brazil., Rolim Medeiros JV; Laboratory of Pharmacology of Inflammation and Gastrointestinal Disorders (LAFIDG), Universidade Federal do Delta do Parnaíba (UFDPar), Parnaíba 64202-020, PI, Brazil., Sabia Tallo F; Department of Urgency and Emergency Care, Universidade Federal de São Paulo (UNIFESP), São Paulo 04023-062, SP, Brazil., Omar Taha M; Department of Surgery, Universidade Federal de São Paulo (UNIFESP), São Paulo 04023-062, SP, Brazil., Yamaguti Lima R; School of Medicine, Universidade Santo Amaro (UNISA), São Paulo 04829-300, SP, Brazil.; Postgraduate Program in Cardiology, Universidade Federal de São Paulo (UNIFESP), São Paulo 04023-062, SP, Brazil., Caricati-Neto A; Department of Pharmacology, Universidade Federal de São Paulo (UNIFESP), São Paulo 04023-062, SP, Brazil., Menezes-Rodrigues FS; School of Medicine, Universidade Santo Amaro (UNISA), São Paulo 04829-300, SP, Brazil.; Postgraduate Program in Cardiology, Universidade Federal de São Paulo (UNIFESP), São Paulo 04023-062, SP, Brazil.

Publikováno v: Journal of cardiovascular development and disease [J Cardiovasc Dev Dis] 2022 Dec 02; Vol. 9 (12). Date of Electronic Publication: 2022 Dec 02.